Bowel obstruction in advanced tubo-ovarian cancer: a retrospective cohort study
暂无分享,去创建一个
P. Neven | I. Vergote | A. Wolthuis | Sileny N. Han | E. Van Nieuwenhuysen | E. Oldenburger | Jolien Jansen | Jente Jansen
[1] P. Bradley,et al. STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery , 2021, Annals of medicine and surgery.
[2] Youguo Chen,et al. Palliative treatment for bowel obstruction in ovarian cancer: a meta-analysis , 2020, Archives of Gynecology and Obstetrics.
[3] S. Yamada,et al. Malignant bowel obstruction due to uterine or ovarian cancer: Are there differences in outcome? , 2019, Gynecologic oncology.
[4] A. Poveda,et al. Malignant Bowel Obstruction in Relapsed Ovarian Cancer With Peritoneal Carcinomatosis: An Occlusive State , 2017, International Journal of Gynecologic Cancer.
[5] D. Bodurka,et al. Treatment Patterns, Outcomes, and Costs for Bowel Obstruction in Ovarian Cancer , 2017, International Journal of Gynecologic Cancer.
[6] Miriam J. Johnson,et al. Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic Review. , 2016, Journal of pain and symptom management.
[7] D. J. Koo,et al. Malignant Bowel Obstruction in Advanced Cancer , 2016 .
[8] A. Jatoi,et al. Malignant Bowel Obstruction in Patients With Recurrent Ovarian Cancer , 2016, The American journal of hospice & palliative care.
[9] H. Helland,et al. Challenges and outcome of surgery for bowel obstruction in women with gynaecologic cancer. , 2016, International journal of surgery.
[10] R. Wolff,et al. Retrospective analysis of systemic chemotherapy and total parenteral nutrition for the treatment of malignant small bowel obstruction , 2015, Cancer medicine.
[11] A. Abernethy,et al. Double-blind, placebo-controlled, randomized trial of octreotide in malignant bowel obstruction. , 2015, Journal of pain and symptom management.
[12] N. Biglia,et al. Palliative care in patients with ovarian cancer and bowel obstruction , 2015, Supportive Care in Cancer.
[13] Sanyuan Hu,et al. Randomized clinical trial comparing octreotide and scopolamine butylbromide in symptom control of patients with inoperable bowel obstruction due to advanced ovarian cancer , 2015, World Journal of Surgical Oncology.
[14] L. Hogen,et al. Bowel obstruction in recurrent gynecologic malignancies: defining who will benefit from surgical intervention. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[15] Jason D. Wright,et al. Bowel obstruction in elderly ovarian cancer patients: a population-based study. , 2013, Gynecologic oncology.
[16] S. Mercadante,et al. Octreotide for malignant bowel obstruction: twenty years after. , 2012, Critical reviews in oncology/hematology.
[17] E. Guell,et al. Malignant bowel obstruction in advanced cancer patients: epidemiology, management, and factors influencing spontaneous resolution , 2012, Cancer management and research.
[18] M. Gore,et al. Outcomes of surgical management of bowel obstruction in relapsed epithelial ovarian cancer (EOC). , 2012, Gynecologic oncology.
[19] D. Jayne,et al. Parenteral nutrition for patients with advanced ovarian malignancy. , 2011, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[20] D. Barton,et al. Surgical management of bowel obstruction in gynaecological malignancies , 2011, Current opinion in supportive and palliative care.
[21] D. Selby,et al. Room for improvement? A quality-of-life assessment in patients with malignant bowel obstruction , 2010, Palliative medicine.
[22] M. D. del Carmen,et al. Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer , 2010, BJOG : an international journal of obstetrics and gynaecology.
[23] I. Vergote,et al. Surgical program building in advanced ovarian cancer: European perspective. , 2009, Gynecologic oncology.
[24] E. Sartori,et al. Bowel Obstruction and Survival in Patients With Advanced Ovarian Cancer: Analysis of Prognostic Variables , 2009, International Journal of Gynecologic Cancer.
[25] H. Gerdes,et al. Management of malignant bowel obstruction. , 2008, European journal of cancer.
[26] S. Coughlin,et al. Complications at the end of life in ovarian cancer. , 2007, Journal of pain and symptom management.
[27] S. Mercadante,et al. Medical treatment for inoperable malignant bowel obstruction: a qualitative systematic review. , 2007, Journal of pain and symptom management.
[28] Richard G. Moore,et al. The effect of total parenteral nutrition on the survival of terminally ill ovarian cancer patients. , 2006, Gynecologic oncology.
[29] M. Franchi,et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis , 2004, International Journal of Gynecologic Cancer.
[30] S. Orsulic,et al. Ovarian Cancer , 1993, British Journal of Cancer.
[31] E. Somers. International Agency for Research on Cancer. , 1985, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.